These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6997895)

  • 21. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A; Guo JP; Ma XL; Lefer AM
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin-induced hemodynamic changes in dogs: role of thromboxane and prostaglandin I2.
    Bottoms GD; Johnson MA; Roesel OF
    Am J Vet Res; 1983 Aug; 44(8):1497-500. PubMed ID: 6354015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Am J Physiol; 1979 Feb; 236(2):H280-5. PubMed ID: 311160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin suppresses the early cardiodepressant factor released by endotoxin in the rat: possible involvement of a prostacyclin-related material.
    Carli A; Auclair MC; Vernimmen C
    Adv Shock Res; 1983; 10():161-71. PubMed ID: 6349296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin reversal of lethal endotoxemia in dogs.
    Krausz MM; Utsunomiya T; Feuerstein G; Wolfe JH; Shepro D; Hechtman HB
    J Clin Invest; 1981 Apr; 67(4):1118-25. PubMed ID: 7009654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxic shock in the rabbit: the effects of prostaglandin and arachidonic acid administration.
    Flynn JT
    J Pharmacol Exp Ther; 1978 Sep; 206(3):555-66. PubMed ID: 359777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxic shock after long-term resuscitation of hemorrhage/reperfusion injury decreased splanchnic blood flow and eicosanoid release.
    Myers SI; Tumage RH; Kadesky KM; Seelig AR; Bartula L
    Ann Surg; 1996 Aug; 224(2):213-8. PubMed ID: 8757386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
    VanAntwerp DR; Hedley LR; Spires DA; Strosberg AM; Johnson G; Lefer AM
    Eicosanoids; 1991; 4(1):15-20. PubMed ID: 2059456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
    Galvin MJ; Lefer AM
    Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of prostaglandin F2alpha during splanchnic artery occlusion shock.
    Flynn JT; Bridenbaugh GA; Lefer AM
    Am J Physiol; 1976 Mar; 230(3):684-90. PubMed ID: 1266970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental endotoxemia in the rat: efficacy of prostacyclin or the prostacyclin analog iloprost.
    Smith EF; Tempel GE; Wise WC; Halushka PV; Cook JA
    Circ Shock; 1985; 16(1):1-7. PubMed ID: 2414027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H; Smith BA; Lefer AM
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE; Johnson G; Siegfried M; Lefer AM
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.